sipatrigine has been researched along with Anterior Circulation Transient Ischemic Attack in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (80.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dewar, D; McCracken, E; McCulloch, J | 1 |
Daly, D; Durant, GJ; Fischer, JB; Goldin, SM; Hu, LY; Knapp, AG; Magar, S; Reddy, NL; Sharma, R; Subbarao, K | 1 |
Leach, MJ; Swan, JH | 1 |
Graham, SH; Kawaguchi, K | 1 |
Henshall, DC; Kawaguchi, K; Simon, RP | 1 |
1 review(s) available for sipatrigine and Anterior Circulation Transient Ischemic Attack
Article | Year |
---|---|
Neuroprotective use-dependent blockers of Na+ and Ca2+ channels controlling presynaptic release of glutamate.
Topics: Animals; Blood Pressure; Brain; Calcium Channel Blockers; CHO Cells; Cricetinae; Electrophysiology; Glutamic Acid; Guanidines; Heart Rate; Ischemic Attack, Transient; Kinetics; Neuroprotective Agents; Neurotransmitter Uptake Inhibitors; Piperazines; Pyrimidines; Rats; Receptors, N-Methyl-D-Aspartate; Recombinant Proteins; Sodium Channel Blockers; Sodium Channels | 1995 |
4 other study(ies) available for sipatrigine and Anterior Circulation Transient Ischemic Attack
Article | Year |
---|---|
Sipatrigine and oligodendrocyte and axonal pathology following transient focal cerebral ischaemia in the rat.
Topics: Animals; Axons; Ischemic Attack, Transient; Male; Neurons; Neuroprotective Agents; Oligodendroglia; Piperazines; Pyrimidines; Rats; Rats, Sprague-Dawley | 2003 |
Evaluation of the novel neuroprotective agent BW619C89 in the middle cerebral artery occlusion model of focal ischemia in the spontaneously hypertensive rat and normotensive Fischer 344 rat.
Topics: Animals; Caudate Nucleus; Cerebral Arteries; Cerebral Infarction; Hippocampus; Ischemic Attack, Transient; Neuroprotective Agents; Piperazines; Pyrimidines; Rats; Rats, Inbred F344; Rats, Inbred SHR; Species Specificity | 1995 |
Neuroprotective effects of the glutamate release inhibitor 619C89 in temporary middle cerebral artery occlusion.
Topics: Animals; Blood Gas Analysis; Cerebral Arteries; Cerebral Infarction; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Ischemic Attack, Transient; Male; Neostriatum; Neuroprotective Agents; Piperazines; Pyrimidines; Rats; Rats, Sprague-Dawley; Reperfusion Injury | 1997 |
Parallel dose-response studies of the voltage-dependent Na+ channel antagonist BW619C89, and the voltage-dependent Ca2+ channel antagonist nimodipine, in rat transient focal cerebral ischaemia.
Topics: Animals; Blood Glucose; Blood Pressure; Body Temperature; Brain; Calcium Channel Blockers; Dose-Response Relationship, Drug; Electric Stimulation; Hydrogen-Ion Concentration; Ischemic Attack, Transient; Male; Neuroprotective Agents; Nimodipine; Piperazines; Pyrimidines; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Sodium Channel Blockers | 1999 |